For the quarter ending 2025-09-30, ISCO made $2,369K in revenue. $29K in net income. Net profit margin of 1.22%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Product sales | 2,369 | 2,447 | 2,129 | 2,302 |
| Cost of sales | 1,048 | 927 | 992 | 930 |
| General and administrative | 789 | 905 | 892 | 900 |
| Selling and marketing | 280 | 286 | 273 | 308 |
| Research and development | 158 | 162 | 187 | 157 |
| Total operating expenses | 2,275 | 2,280 | 2,344 | 2,295 |
| Income (loss) from operations | 94 | 167 | -215 | 7 |
| Other income, net | - | - | - | 1 |
| Interest expense | 1 | 2 | 3 | 37 |
| Interest expense - related party | 36 | 36 | 38 | - |
| Total other expense, net | -37 | -38 | -41 | -35 |
| Net income (loss) | 57 | 129 | -256 | -28 |
| Undistributed earnings allocated to participating securities | 28 | 62 | - | - |
| Net income (loss) attributable to common stockholders | 29 | 67 | - | - |
| Earnings per share, basic, total | 0 | 0.01 | -0.03 | -0.003 |
| Earnings per share, diluted, total | 0 | 0.01 | -0.03 | -0.003 |
| Weighted average number of shares outstanding, basic, total | 8,004,389 | 8,004,389 | 8,004,389 | 0 |
| Weighted average number of shares outstanding, diluted | 8,167,297 | 8,004,389 | 8,004,389 | 0 |
International Stem Cell CORP (ISCO)
International Stem Cell CORP (ISCO)